Combivent side effects

List of side effects
Observed in two 12-week controlled clinical trials Additional adverse reactions Allergic-type reactions

Observed in two 12-week controlled clinical trials
The following adverse reactions concerning Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol were observed two 12-week controlled clinical trials (N=358 for Combivent Inhalation Aerosol):
 * Body as a whole/general disorders: headache, pain, influenza, chest pain
 * Gastrointestinal system disorders: nausea
 * Lower respiratory system disorders: bronchitis, dyspnea, coughing, respiratory disorders, pneumonia, bronchospasm
 * Upper respiratory system disorders: upper respiratory tract infection, pharyngitis, sinusitis, rhinitis Return to top

Additional adverse reactions
Additional adverse reactions, reported in less than two percent of the patients in the Combivent Inhalation Aerosol treatment group include edema, fatigue, hypertension, dizziness, nervousness, paresthesia, tremor, dysphonia, insomnia, diarrhea, dry mouth, dyspepsia, vomiting, arrhythmia, palpitation, tachycardia, arthralgia, angina, increased sputum, taste perversion, and urinary tract infection/dysuria. Return to top

Allergic-type reactions
Allergic-type reactions such as skin rash, angioedema of tongue, lips and face, urticaria (including giant urticaria), laryngospasm and anaphylactic reaction have been reported with Combivent Inhalation Aerosol, with positive rechallenge in some cases. Many of these patients had a history of allergies to other drugs and/or foods including soybean. Return to top